Immune responses related to the immunogenicity and reactogenicity of COVID-19 mRNA vaccines

被引：15

作者：

Matsumura, Takayuki ^{[1
]}

Takano, Tomohiro ^{[1
]}

Takahashi, Yoshimasa ^{[1
]}

机构：

[1] Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, 1-23-1 Toyama,Shinjuku Ku, Tokyo 1628640, Japan

来源：

INTERNATIONAL IMMUNOLOGY | 2023年 / 35卷 / 05期

基金：

日本学术振兴会;

关键词：

acquired immunity; adverse event; innate immunity; lipid nanoparticle; SARS-CoV-2 spike protein; T-HELPER TYPE-1; INFLUENZA VACCINATION; CELLS; ACTIVATION; DIFFERENTIATION; RECOGNITION; ANTIBODY; DISTINCT; SUBSET;

D O I：

10.1093/intimm/dxac064

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vaccination for the prevention of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is considered the most promising approach to control the pandemic of coronavirus disease 2019 (COVID-19). Although various COVID-19 vaccines have been developed worldwide using several modalities, the vaccines that have shown the highest efficacy to date are mRNA vaccines. Despite their extensive usage, the mechanisms that stimulate the immune responses associated with their immunogenicity and reactogenicity remain largely unknown. In this review, we summarize and discuss current knowledge on immune responses to COVID-19 mRNA vaccines, including potential immune responses and correlating factors underlying the immunogenicity and reactogenicity of mRNA vaccines. We also describe recent trends in the optimization of lipid nanoparticles and vaccination routes. Further understanding of vaccine-elicited immune responses will guide the development of more effective and safe vaccines.

引用

页码：213 / 220

页数：8

共 93 条

[31] SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies [J].

Hoffmann, Markus ;

Arora, Prerna ;

Gross, Rudiger ;

Seidel, Alina ;

Hornich, Bojan F. ;

Hahn, Alexander S. ;

Kruger, Nadine ;

Graichen, Luise ;

Hofmann-Winkler, Heike ;

Kempf, Amy ;

Winkler, Martin S. ;

Schulz, Sebastian ;

Jack, Hans-Martin ;

Jahrsdorfer, Bernd ;

Schrezenmeier, Hubert ;

Muller, Martin ;

Kleger, Alexander ;

Munch, Jan ;

Pohlmann, Stefan .

CELL, 2021, 184 (09) :2384-+

[32] DEVELOPMENT OF TH1 CD4+ T-CELLS THROUGH IL-12 PRODUCED BY LISTERIA-INDUCED MACROPHAGES [J].

HSIEH, CS ;

MACATONIA, SE ;

TRIPP, CS ;

WOLF, SF ;

OGARRA, A ;

MURPHY, KM .

SCIENCE, 1993, 260 (5107) :547-549

[33] Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection [J].

Javier Morales-Nunez, Jose ;

Francisco Munoz-Valle, Jose ;

Meza-Lopez, Carlos ;

Wang, Lin-Fa ;

Machado Sulbaran, Andrea Carolina ;

Carolina Torres-Hernandez, Paola ;

Bedolla-Barajas, Martin ;

De la O-Gomez, Brenda ;

Balcazar-Felix, Paulina ;

Hernandez-Bello, Jorge .

VACCINES, 2021, 9 (07)

[34] BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality [J].

Jung, Min Kyung ;

Jeong, Seong Dong ;

Noh, Ji Yun ;

Kim, Dong-Uk ;

Jung, Sungmin ;

Song, Joon Young ;

Jeong, Hye Won ;

Park, Su-Hyung ;

Shin, Eui-Cheol .

NATURE MICROBIOLOGY, 2022, 7 (06) :909-+

[35] mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions [J].

Kaplonek, Paulina ;

Cizmeci, Deniz ;

Fischinger, Stephanie ;

Collier, Ai-Ris ;

Suscovich, Todd ;

Linde, Caitlyn ;

Broge, Thomas ;

Mann, Colin ;

Amanat, Fatima ;

Dayal, Diana ;

Rhee, Justin ;

Aubin, Michael de St ;

Nilles, Eric J. ;

Musk, Elon R. ;

Menon, Anil S. ;

Saphire, Erica Ollmann ;

Krammer, Florian ;

Lauffenburger, Douglas A. ;

Barouch, Dan H. ;

Alter, Galit .

SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (645)

[36] Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA [J].

Karikó, K ;

Buckstein, M ;

Ni, HP ;

Weissman, D .

IMMUNITY, 2005, 23 (02) :165-175

[37] Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability [J].

Kariko, Katalin ;

Muramatsu, Hiromi ;

Welsh, Frank A. ;

Ludwig, Janos ;

Kato, Hiroki ;

Akira, Shizuo ;

Weissman, Drew .

MOLECULAR THERAPY, 2008, 16 (11) :1833-1840

[38] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].

Khoury, David S. ;

Cromer, Deborah ;

Reynaldi, Arnold ;

Schlub, Timothy E. ;

Wheatley, Adam K. ;

Juno, Jennifer A. ;

Subbarao, Kanta ;

Kent, Stephen J. ;

Triccas, James A. ;

Davenport, Miles P. .

NATURE MEDICINE, 2021, 27 (07) :1205-+

[39] Germinal centre-driven maturation of B cell response to mRNA vaccination [J].

Kim, Wooseob ;

Zhou, Julian Q. ;

Horvath, Stephen C. ;

Schmitz, Aaron J. ;

Sturtz, Alexandria J. ;

Lei, Tingting ;

Liu, Zhuoming ;

Kalaidina, Elizaveta ;

Thapa, Mahima ;

Alsoussi, Wafaa B. ;

Haile, Alem ;

Klebert, Michael K. ;

Suessen, Teresa ;

Parra-Rodriguez, Luis ;

Mudd, Philip A. ;

Whelan, Sean P. J. ;

Middleton, William D. ;

Teefey, Sharlene A. ;

Pusic, Iskra ;

O'Halloran, Jane A. ;

Presti, Rachel M. ;

Turner, Jackson S. ;

Ellebedy, Ali H. .

NATURE, 2022, 604 (7904) :141-+

[40] Surveillance for Adverse Events After COVID-19 mRNA Vaccination [J].

Klein, Nicola P. ;

Lewis, Ned ;

Goddard, Kristin ;

Fireman, Bruce ;

Zerbo, Ousseny ;

Hanson, Kayla E. ;

Donahue, James G. ;

Kharbanda, Elyse O. ;

Naleway, Allison ;

Nelson, Jennifer Clark ;

Xu, Stan ;

Yih, W. Katherine ;

Glanz, Jason M. ;

Williams, Joshua T. B. ;

Hambidge, Simon J. ;

Lewin, Bruno J. ;

Shimabukuro, Tom T. ;

DeStefano, Frank ;

Weintraub, Eric S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14) :1390-1399

← 1 2 3 4 5 6 7 8 9 10 →